Farther Finance Advisors, LLC

Position in GILD — Gilead Sciences, Inc.

CIK 1992825 SAN FRANCISCO, CA

Position in GILD

as of Jun 30, 2026 · filed Jul 17, 2026 Compact

Position Value

$7,388,110

-$500,928 QoQ

Shares Held

58,478

+3.3% QoQ

Ownership

0.005%

of shares outstanding

% of Portfolio

0.18%

of 13F equity value

Holder Rank

#113

of 913 holders

Holding Since

Dec 2022

15 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Farther Finance Advisors, LLC holds $187,005,351 across 18 Drug Manufacturers - General names. GILD ranks #8 (4.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	43,809	$52,545,833
2	JNJ	Johnson & Johnson	135,612	$34,441,379
3	ABBV	AbbVie Inc.	119,959	$30,186,482
4	MRK	Merck & Co., Inc.	120,685	$15,508,022
5	AMGN	Amgen Inc	34,711	$12,569,547
6	PFE	Pfizer Inc	395,297	$9,518,751
7	BMY	Bristol Myers Squibb Co	148,017	$8,528,739
8	GILD	Gilead Sciences, Inc. This page	58,478	$7,388,110

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$7,388,110	58,478	+3.3%	Shares	Sole	2026-07-17
2026-03-31	$7,889,038	56,605	-0.4%	Shares	Sole	2026-04-07
2025-12-31	$6,973,104	56,812	+43.9%	Shares	Sole	2026-01-23
2025-09-30	$4,383,057	39,487	-5.3%	Shares	Sole	2025-10-14
2025-06-30	$4,624,387	41,710	+11.3%	Shares	Sole	2025-07-11
2025-03-31	$4,200,418	37,487	+94.3%	Shares	Sole	2025-04-14
2024-12-31	$1,782,094	19,293	+8.5%	Shares	Sole	2025-02-10
2024-09-30	$1,490,256	17,775	+3.2%	Shares	Sole	2024-10-29
2024-06-30	$1,182,013	17,228	+0.5%	Shares	Sole	2024-07-31
2024-03-31	$1,256,164	17,149	-31.8%	Shares	Sole	2024-05-14
2023-12-31	$2,035,700	25,129	+164.2%	Shares	Sole	2024-02-15
2023-09-30	$712,754	9,511	+45.7%	Shares	Sole	2023-11-14
2023-06-30	$503,190	6,529	+3.1%	Shares	Sole	2024-05-14
2023-03-31	$525,200	6,330	+379.5%	Shares	Sole	2024-05-14
2022-12-31	$113,322	1,320	—	Shares	Sole	2023-09-12
No filing history on record for this holder in this stock.